AIDX (AIDX)
0.83
+0.03 (3.75%)
Upcoming Events
Latest Headlines
Form PRE 14A 20/20 Biolabs, Inc. For: Jun 01
June 1, 2026 4:41 PM - SEC Filing
20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters
May 27, 2026 8:31 AM - Globe NewsWire
20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters
May 27, 2026 8:31 AM - StreetInsider
Form 8-K 20/20 Biolabs, Inc. For: May 19
May 26, 2026 4:41 PM - SEC Filing
20/20 Biolabs prepares contingency plans for Ebola and Hantavirus testing
May 22, 2026 8:31 AM - StreetInsider
20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand
May 22, 2026 8:31 AM - Globe NewsWire
20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand
May 22, 2026 8:31 AM - StreetInsider
Form 424B3 20/20 Biolabs, Inc.
May 21, 2026 4:11 PM - SEC Filing
Form 424B3 20/20 Biolabs, Inc.
May 21, 2026 4:10 PM - SEC Filing
Form 10-Q 20/20 Biolabs, Inc. For: Mar 31
May 20, 2026 4:19 PM - SEC Filing
Form 8-K 20/20 Biolabs, Inc. For: May 20
May 20, 2026 4:11 PM - SEC Filing
20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress
May 20, 2026 4:05 PM - StreetInsider
Form NT 10-Q 20/20 Biolabs, Inc. For: Mar 31
May 15, 2026 4:29 PM - SEC Filing
20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026
May 14, 2026 8:31 AM - Globe NewsWire
20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina
May 12, 2026 8:32 AM - StreetInsider
20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina
May 12, 2026 8:31 AM - Globe NewsWire
Maxim Group Starts 20/20 Biolabs (AIDX) at Buy
May 11, 2026 7:40 AM - StreetInsider
Form 424B3 20/20 Biolabs, Inc.
April 28, 2026 7:59 AM - SEC Filing
Form 424B3 20/20 Biolabs, Inc.
April 28, 2026 7:57 AM - SEC Filing
Form 8-K 20/20 Biolabs, Inc. For: Apr 23
April 28, 2026 7:43 AM - SEC Filing
Form 424B3 20/20 Biolabs, Inc.
April 13, 2026 4:29 PM - SEC Filing
Form 424B3 20/20 Biolabs, Inc.
April 13, 2026 4:29 PM - SEC Filing
Form EFFECT 20/20 Biolabs, Inc.
April 13, 2026 6:04 AM - SEC Filing
BIO-key International, 20/20 Biolabs, Society Pass, and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
April 10, 2026 10:00 AM - StreetInsider
Form EFFECT 20/20 Biolabs, Inc.
April 10, 2026 6:03 AM - SEC Filing
20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform
April 7, 2026 12:50 PM - Globe NewsWire
20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform
April 7, 2026 8:41 AM - StreetInsider
Form 4 20/20 Biolabs, Inc. For: Apr 02 Filed by: Bergman Alan B.
April 6, 2026 5:57 PM - SEC Filing
Form 4 20/20 Biolabs, Inc. For: Apr 02 Filed by: Zhou Jiming
April 6, 2026 5:56 PM - SEC Filing
Form S-1 20/20 Biolabs, Inc.
April 6, 2026 5:30 PM - SEC Filing
Form POS AM 20/20 Biolabs, Inc.
April 6, 2026 5:22 PM - SEC Filing
Form 8-K 20/20 Biolabs, Inc. For: Mar 31
April 1, 2026 6:03 AM - SEC Filing
Form 10-K 20/20 Biolabs, Inc. For: Dec 31
March 31, 2026 5:27 PM - SEC Filing
20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress
March 31, 2026 4:57 PM - Globe NewsWire
Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs’ OneTest ™ Multi-Cancer Early Detection Blood Test
March 27, 2026 8:31 AM - StreetInsider
20/20 BioLabs licenses kidney disease prediction tech from ROKIT Healthcare
March 24, 2026 8:31 AM - StreetInsider
20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program
March 24, 2026 8:31 AM - StreetInsider
20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies
March 12, 2026 8:31 AM - StreetInsider
Form SCHEDULE 13G 20/20 Biolabs, Inc. Filed by: Full Succeed International Ltd
March 10, 2026 5:18 PM - SEC Filing
Form SCHEDULE 13D 20/20 Biolabs, Inc. Filed by: Cohen Jonathan M
March 10, 2026 5:14 PM - SEC Filing
Full Article List